Wasatch Hldg Stock

Wasatch Hldg Equity

The The Equity of Wasatch Hldg (BICB) as of Aug 13, 2026 is -1.20 M USD.

Equity

-1.20 MUSD

Last updated:

In 2026, Wasatch Hldg's equity was -1.20 M USD, a % increase from the - USD equity in the previous year.

Access this data via the Eulerpool API

Wasatch Hldg Stock analysis

What does Wasatch Hldg do? Biocube Inc is a leading company in the biotechnology industry, offering innovative products and services since its establishment in 1995. The company was founded by a group of researchers and scientists dedicated to developing innovative solutions for biotechnological challenges. It has received numerous awards and recognition for its significant contributions to research and science. The business model of Biocube Inc focuses on the development and marketing of biotechnology products, software, and services in all areas of biology. It has several business divisions, including bioprocess development, bioprocess research, bioanalytics and diagnostics, laboratory equipment, and software development. The bioprocess development division focuses on developing new biotechnological processes and products. The company holds numerous patents on important biotechnological procedures and products such as DNA sequencing, cell culture, and protein expression. Biocube Inc collaborates closely with partners in industry and academia to advance new biotechnological developments that can contribute to improving healthcare, food supply, and industrial production. The bioprocess research division is responsible for continuously improving existing biotechnological procedures and products to enhance their efficiency and cost-effectiveness. The company invests in research and development of new biotechnological procedures and products to strengthen its competitive position in this field. Bioanalytics and diagnostics are other important business divisions of Biocube Inc. The company has developed an extensive portfolio of analytical and diagnostic tools that enable rapid and accurate disease diagnosis and assessment of environmental conditions. It also has a strong presence in the animal health industry, offering innovative diagnostic technologies for pets, livestock, and wildlife. Laboratory equipment is another significant area of the company. Biocube Inc provides a wide range of laboratory equipment, materials, and reagents. This includes PCR systems, liquid chromatography systems, mass spectrometers, centrifuges, and various types of laboratory containers. Additionally, the company also offers specialized hardware and software based on biological applications, specifically designed for the requirements of life science research. Software development is another business field of Biocube Inc. The company has developed a variety of software tools to support and automate biomedical research tasks. These tools include data-driven analysis systems, information visualization, machine learning algorithms, and automated workflows for biological experiments. Overall, it can be said that Biocube Inc has played a leading role in the biotechnology industry from the beginning. Through its innovative products and services, the company has contributed to advancing the development of biotechnology processes and products in industry and academia. Biocube Inc is sure to continue making dedicated contributions to improving healthcare, food supply, and industrial production in the future. The company aims to achieve strong growth and a successful future through innovation and excellence in research and development. Wasatch Hldg is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Wasatch Hldg's Equity

Wasatch Hldg's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Wasatch Hldg's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Wasatch Hldg's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Wasatch Hldg's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Wasatch Hldg’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Wasatch Hldg stock

The Equity of Wasatch Hldg is -1.20 M USD in 2026.

On Eulerpool you can find the complete historical development of The Equity Wasatch Hldg since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Wasatch Hldg historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Wasatch Hldg

All Key Metrics — Wasatch Hldg